Literature DB >> 29064259

Editor's Choice-The cardiovascular implications of sedatives in the cardiac intensive care unit.

Sammy Zakaria1, Helaine J Kwong1, Jonathan E Sevransky2, Marlene S Williams1, Nisha Chandra-Strobos1.   

Abstract

Patients admitted to the cardiac intensive care unit frequently develop multi-organ system dysfunction associated with their cardiac disease. In many cases, invasive mechanical ventilation is required, which often necessitates sedation for patient-ventilator synchrony, reduction of work of breathing, and patient comfort. In this paper, we describe the use of common sedatives available in the endotracheally intubated critically ill patient and emphasize the clinical and cardiovascular effects. We review γ-aminobutyric acid agonists such as etomidate, benzodiazepines, and propofol, the centrally acting α2-agonist dexmedetomidine, and the N-methyl-D-aspartate receptor antagonist ketamine. Additionally, we outline the use of opioids and their role in potentiating other sedatives. We note that some sedatives are associated with increased delirium rates, and emphasize that judicious strategies minimizing sedative use are associated with decreases in morbidity and mortality. We also discuss standardized sedation assessment scales and highlight the importance of sedation weaning. Finally, we offer recommendations for sedation use during therapeutic hypothermia, and discuss the use of adjuvant neuromuscular blocking agents.

Entities:  

Keywords:  Sedation; benzodiazepines; cardiac critical care; dexmedetomidine; intensive care unit; ketamine; opioids; propofol; sedation assessment

Mesh:

Substances:

Year:  2017        PMID: 29064259     DOI: 10.1177/2048872617695231

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  1 in total

1.  Development and Internal Validation of a New Prognostic Model Powered to Predict 28-Day All-Cause Mortality in ICU COVID-19 Patients-The COVID-SOFA Score.

Authors:  Emanuel Moisa; Dan Corneci; Mihai Ionut Negutu; Cristina Raluca Filimon; Andreea Serbu; Mihai Popescu; Silvius Negoita; Ioana Marina Grintescu
Journal:  J Clin Med       Date:  2022-07-18       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.